Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret? -- Ignore unavailable to you. Want to Upgrade?

To: Todd D. Wiener who wrote (649)	2/6/1998 2:24:00 PM
From: Jim Roof	Respond to of 1432

Yeah? Well... what does HE know? :-)

To: Todd D. Wiener who wrote (649)	2/6/1998 3:10:00 PM
From: Stephen How	Read Replies (2) \| Respond to of 1432

Today, a form 4 filing was published with the SEC. It shows that Hal Sternberg, VP and director of BioTime, purchased 3,000 shares in the open market on January. Thanks Todd, your post was very interesting. I noticed that Hal Sternberg filed a 13D in Sept 97, but it only indicated he held less than 5% of the company. Is he, as a director, subject to filing a Form 4 for any change in his BTIM ownership under SEC 16(a)? Is the same true for any director or officer of the company? Would there be any SEC filing if the margined shares (mentioned in my last posts) were to be sold by Montgomery Securities in a margin call? Thx, Steve